用于心血管风险评估的载脂蛋白。 - Suppr | 超能文献

Apolipoproteins for cardiovascular risk assessment.

作者信息

Chang Jennifer G, Paulson Christopher P, Smith Rita F

机构信息

Offutt Air Force Base Family Medicine Residency, Offutt Air Force Base, NE, USA.

Eglin Air Force Base Family Medicine Residency, Eglin Air Force Base, FL, USA.

出版信息

Am Fam Physician. 2014 Apr 15;89(8):Online.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Apolipoproteins for cardiovascular risk assessment.用于心血管风险评估的载脂蛋白。

Am Fam Physician. 2014 Apr 15;89(8):Online.

2

Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease.引言：载脂蛋白与心血管疾病预防指南

J Intern Med. 2006 May;259(5):434-6. doi: 10.1111/j.1365-2796.2006.01650.x.

3

[Apolipoproteins are better risk markers than conventional lipids].载脂蛋白比传统脂质是更好的风险标志物。

Lakartidningen. 2007;104(37):2612-3.

4

[The importance of A1 and B apoproteins as cardiovascular risk markers].[A1和B载脂蛋白作为心血管风险标志物的重要性]

An Med Interna. 2008 Apr;25(4):199-200. doi: 10.4321/s0212-71992008000400013.

5

Cardiovascular risk according to plasma apolipoprotein and lipid profiles in a Canadian First Nation.加拿大第一民族人群中基于血浆载脂蛋白和血脂谱的心血管疾病风险

Chronic Dis Can. 2010 Dec;31(1):33-8.

6

[Plasma apolipoproteins: their role in cardiovascular diseases and usefulness of their blood concentration determination. Committee of the Study of Apolipoproteins, Italian Heart Foundation].[血浆载脂蛋白：它们在心血管疾病中的作用及其血液浓度测定的用途。意大利心脏基金会载脂蛋白研究委员会]

Cardiologia. 1997 Feb;42 Suppl 1:1-39.

7

Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I--new risk factors and targets for therapy.是否存在比低密度脂蛋白胆固醇更好的心血管风险标志物？载脂蛋白B和A-I——新的风险因素及治疗靶点。

Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):565-71. doi: 10.1016/j.numecd.2007.02.010. Epub 2007 Jul 16.

8

ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk.载脂蛋白 B/载脂蛋白 A-I 比值比 LDL-C 更能检测心血管风险。

Nutr Metab Cardiovasc Dis. 2011 Jun;21(6):406-11. doi: 10.1016/j.numecd.2009.11.002. Epub 2010 Feb 19.

9

[Should apolipoproteins be the first choice in routine health care?].[载脂蛋白应成为常规医疗保健的首选指标吗？]

Lakartidningen. 2007;104(42):3124.

10

Clinical utility of low-density lipoprotein particles and apolipoprotein B in patients with cardiovascular risk.低密度脂蛋白颗粒和载脂蛋白B在心血管风险患者中的临床应用价值。

J Fam Pract. 2013 Jul;62(7 Suppl):1-8.

引用本文的文献

1

Demystifying the nuances of the lipid patient: a guide for primary care providers.揭开血脂异常患者的细微差别：初级保健提供者指南

Am J Prev Cardiol. 2025 Jul 26;23:101070. doi: 10.1016/j.ajpc.2025.101070. eCollection 2025 Sep.

2

Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE).国际病例对照研究（INTERSTROKE）中脂质、脂蛋白和载脂蛋白与中风亚型的关联

J Stroke. 2022 May;24(2):224-235. doi: 10.5853/jos.2021.02152. Epub 2022 May 31.